New combo treatment aims to save hips from collapse
NCT ID NCT05706909
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a procedure for people with early-stage osteonecrosis (bone death) of the hip. Doctors drill into the hip bone, inject a concentrated sample of the patient's own bone marrow, and add a special bone graft material called Genex. The goal is to see if this helps bone heal, prevents further collapse, and reduces pain. The trial involves 22 participants and is being run by the Cleveland Clinic.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Genex bone graft substitute with autologous bone marrow concentrate
What this could lead to
If successful, this could offer a way to repair bone damage and avoid hip replacement in people with early-stage osteonecrosis.
What could go wrong
This is a small, early study with only 22 participants, so results may not apply to everyone. The procedure involves surgery and there is no guarantee it will stop the disease from progressing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AVASCULAR NECROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States